$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222033071 Filed on November 21, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$16.97K	$8.340K
YoY Change	-100.0%	103.51%	-40.77%
Cost Of Revenue	$0.00		$0.00
YoY Change	-100.0%
Gross Profit	$0.00	$16.97K	$8.340K
YoY Change	-100.0%	103.51%	-40.77%
Gross Profit Margin		100.0%	100.0%
Selling, General & Admin	$4.193M	$533.0K	$557.8K
YoY Change	186.28%	-4.44%	-9.37%
% of Gross Profit		3140.48%	6688.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$13.23K	$13.24K	$11.92K
YoY Change	-7.87%	11.07%	3.38%
% of Gross Profit		78.01%	142.93%
Operating Expenses	$4.193M	$533.0K	$557.8K
YoY Change	186.28%	-4.44%	-9.37%
Operating Profit	-$4.193M	-$516.1K	-$549.5K
YoY Change	304.88%	-6.08%	-8.63%
Interest Expense	-$1.989M	$631.3K	-$192.6K
YoY Change	374.48%	-427.82%	148.23%
% of Operating Profit
Other Income/Expense, Net	$540.00	-$462.0K	$100.0K
YoY Change		-561.99%
Pretax Income	-$10.42M	-$978.1K	-$642.1K
YoY Change	616.14%	52.33%	-5.44%
Income Tax
% Of Pretax Income
Net Earnings	-$10.42M	-$978.1K	-$642.1K
YoY Change	616.14%	52.33%	-5.44%
Net Earnings / Revenue		-5762.4%	-7698.56%
Basic Earnings Per Share		-$0.03	-$0.02
Diluted Earnings Per Share	-$0.29	-$26.87K	-$21.11K
COMMON SHARES
Basic Shares Outstanding	36.80M shares	36.14M shares	30.42M shares
Diluted Shares Outstanding		36.39M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.37K	$95.84K	$702.0K
YoY Change	-12.76%	-86.35%	4227.93%
Cash & Equivalents	$49.37K	$95.84K	$702.0K
Short-Term Investments
Other Short-Term Assets	$49.20K	$206.1K	$175.2K
YoY Change	-80.45%	17.64%	105.09%
Inventory
Prepaid Expenses
Receivables	$0.00	$55.47K	$101.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$98.57K	$357.4K	$978.7K
YoY Change	-84.16%	-63.48%	862.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.069M	$2.379M	$1.775M
YoY Change	-45.84%	33.99%	29.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$2.280M	$2.719M
YoY Change	-100.0%	-16.15%
Other Assets	$0.00	$647.4K	$690.5K
YoY Change		-6.24%	0.13%
Total Long-Term Assets	$1.069M	$5.699M	$5.185M
YoY Change	-79.58%	9.92%	152.04%
TOTAL ASSETS
Total Short-Term Assets	$98.57K	$357.4K	$978.7K
Total Long-Term Assets	$1.069M	$5.699M	$5.185M
Total Assets	$1.168M	$6.057M	$6.164M
YoY Change	-80.07%	-1.74%	185.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$864.5K	$1.780M	$1.035M
YoY Change	-47.81%	72.02%	100.7%
Accrued Expenses	$485.7K
YoY Change
Deferred Revenue	$85.41K	$487.5K
YoY Change	-32.57%
Short-Term Debt	$1.845M	$1.299M	$854.1K
YoY Change	121.01%	52.08%	139.6%
Long-Term Debt Due	$1.886M	$2.209M	$102.8K
YoY Change	1734.97%	2049.57%	-83.78%
Total Short-Term Liabilities	$5.719M	$6.054M	$2.344M
YoY Change	108.64%	158.32%	39.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.724M
YoY Change	-100.0%	-100.0%	60.04%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$1.724M
YoY Change	-100.0%	-100.0%	60.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.719M	$6.054M	$2.344M
Total Long-Term Liabilities	$0.00	$0.00	$1.724M
Total Liabilities	$5.719M	$6.054M	$4.067M
YoY Change	27.75%	48.85%	47.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.10M	-$19.00M
YoY Change	70.7%
Common Stock	$43.50K	$36.47K
YoY Change	36.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.551M	-$291.2K	$2.096M
YoY Change
Total Liabilities & Shareholders Equity	$1.168M	$6.057M	$6.164M
YoY Change	-80.07%	-1.74%	185.51%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$10.42M	-$978.1K	-$642.1K
YoY Change	616.14%	52.33%	-5.44%
Depreciation, Depletion And Amortization	$13.23K	$13.24K	$11.92K
YoY Change	-7.87%	11.07%	3.38%
Cash From Operating Activities	-$22.02K	-$175.9K	-$338.3K
YoY Change	-93.37%	-48.02%	87.81%
INVESTING ACTIVITIES
Capital Expenditures	$95.40K	-$128.2K	-$70.00K
YoY Change	-133.98%	83.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$100.0K
YoY Change		-100.0%
Cash From Investing Activities	-$95.40K	-$128.2K	-$170.0K
YoY Change	-66.02%	-24.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.740M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	70.95K	394.4K	1.193M
YoY Change	-319.8%	-66.96%	4583.87%
NET CHANGE
Cash From Operating Activities	-22.02K	-175.9K	-338.3K
Cash From Investing Activities	-95.40K	-128.2K	-170.0K
Cash From Financing Activities	70.95K	394.4K	1.193M
Net Change In Cash	-46.47K	90.31K	685.2K
YoY Change	-92.8%	-86.82%	-543.03%
FREE CASH FLOW
Cash From Operating Activities	-$22.02K	-$175.9K	-$338.3K
Capital Expenditures	$95.40K	-$128.2K	-$70.00K
Free Cash Flow	-$117.4K	-$47.65K	-$268.3K
YoY Change	127.82%	-82.24%	48.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001657214
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2021Q1	ILAL	Stock Issued During Period Value From Plot Sale StockIssuedDuringPeriodValueFromPlotSale		usd
CY2021Q1	ILAL	Stock Issued During Period Value Issued For Services One StockIssuedDuringPeriodValueIssuedForServicesOne		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	ILAL	Excess Fair Value Of Derivative ExcessFairValueOfDerivative		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	ILAL	Cash Payment To Collaborative Agreement CashPaymentToCollaborativeAgreement		usd
	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash		usd
	ILAL	Common Stock Issued From Options Exercise CommonStockIssuedFromOptionsExercise		usd
	ILAL	Common Stock Warrants And Plots Promised For Cash Net CommonStockWarrantsAndPlotsPromisedForCashNet		usd
	ILAL	Cash Proceeds From Refinancing Net CashProceedsFromRefinancingNet		usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes		usd
	ILAL	Debt Discount From Bifurcated Derivative DebtDiscountFromBifurcatedDerivative		usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement		usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing		usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote		usd
	ILAL	Shares Issued With Debt Modification SharesIssuedWithDebtModification		usd
	ILAL	Cancellation Of Previously Issued Common Stock CancellationOfPreviouslyIssuedCommonStock		usd
	ILAL	Interest On Notes Paid By Related Party InterestOnNotesPaidByRelatedParty		usd
	ILAL	Construction In Progress Paid By Related Party ConstructionInProgressPaidByRelatedParty		usd
	ILAL	Common Stock Issued As Consideration For Equitymethod Investee CommonStockIssuedAsConsiderationForEquitymethodInvestee		usd
	ILAL	Corporate Expenses Paid Through Related Party Note CorporateExpensesPaidThroughRelatedPartyNote		usd
	ILAL	Common Stock Issued In Settlement Of Related Party Accrued Interest On Note CommonStockIssuedInSettlementOfRelatedPartyAccruedInterestOnNote		usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermExercised
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermForfeited
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeit Canceled Weighted Average Canceled SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitCanceledWeightedAverageCanceled
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56111
	dei	Entity Registrant Name EntityRegistrantName	INTERNATIONAL LAND ALLIANCE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3752361
	dei	Entity Address Address Line1 EntityAddressAddressLine1	350 10th Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1000
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92101
	dei	City Area Code CityAreaCode	(877)
	dei	Local Phone Number LocalPhoneNumber	661-4811
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36796365	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	95841	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56590	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	55472	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30273	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	206110	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	251665	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	357423	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	338528	usd
CY2022Q3	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	283817	usd
CY2021Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	283817	usd
CY2022Q3	us-gaap	Land Land	203419	usd
CY2021Q4	us-gaap	Land Land	203419	usd
CY2022Q3	us-gaap	Land Available For Sale LandAvailableForSale	647399	usd
CY2021Q4	us-gaap	Land Available For Sale LandAvailableForSale	647399	usd
CY2022Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	876847	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	915884	usd
CY2022Q3	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	2012	usd
CY2021Q4	ILAL	Furniture And Equipment Net FurnitureAndEquipmentNet	2682	usd
CY2022Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1296555	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	852020	usd
CY2022Q3	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	100000	usd
CY2022Q3	ILAL	Accrued Interest On Note Receivable AccruedInterestOnNoteReceivable	9153	usd
CY2021Q4	ILAL	Accrued Interest On Note Receivable AccruedInterestOnNoteReceivable	3234	usd
CY2022Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2279985	usd
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2511830	usd
CY2022Q3	us-gaap	Assets Assets	6056610	usd
CY2021Q4	us-gaap	Assets Assets	5858813	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	734613	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1022384	usd
CY2022Q3	ILAL	Accounts Payable And Accrued Liabilities Related Party AccountsPayableAndAccruedLiabilitiesRelatedParty	1045454	usd
CY2021Q4	ILAL	Accounts Payable And Accrued Liabilities Related Party AccountsPayableAndAccruedLiabilitiesRelatedParty	634149	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	487545	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	146663	usd
CY2022Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	500	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	278466	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2208898	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	102762	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1298880	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	834984	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6054356	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2740942	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1735538	usd
CY2022Q3	us-gaap	Liabilities Liabilities	6054356	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4476480	usd
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36471365	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36471365	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31849327	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31849327	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	36472	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	31850	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18707352	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15760772	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19035099	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14703818	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-291246	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6056610	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5858813	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16973	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8340	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50919	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25899	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	16973	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	8340	usd
	us-gaap	Gross Profit GrossProfit	50919	usd
	us-gaap	Gross Profit GrossProfit	25899	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	100600	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	61000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	903283	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1276200	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	432434	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	496822	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2506181	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1917067	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	533034	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	557822	usd
	us-gaap	Operating Expenses OperatingExpenses	3409464	usd
	us-gaap	Operating Expenses OperatingExpenses	3193267	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-516061	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-549482	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3358545	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3167368	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	100000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	536	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	91624	usd
CY2022Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-49752	usd
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	32270	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-231845	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39212	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	219069	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	219069	usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	1534	usd
	us-gaap	Interest Income Other InterestIncomeOther	1534	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	631308	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	226379	usd
	us-gaap	Interest Expense InterestExpense	960496	usd
	us-gaap	Interest Expense InterestExpense	572372	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-461991	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-92575	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-972736	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-440002	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-978052	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-642057	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4331281	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3607370	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36394441	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30418295	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34917678	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26662971	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1088833	usd
CY2022Q1	ILAL	Stock Issued During Period Value Issued Pursuant To Promissory Notes StockIssuedDuringPeriodValueIssuedPursuantToPromissoryNotes	202275	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	447278	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	871688	usd
CY2022Q1	ILAL	Stock Issued During Period With Warrant Issued In Connection With Debt Financing StockIssuedDuringPeriodWithWarrantIssuedInConnectionWithDebtFinancing	159664	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1492722	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1262616	usd
CY2022Q2	ILAL	Stock Issued During Period Value Stock Issued With Finders Fee Agreement StockIssuedDuringPeriodValueStockIssuedWithFindersFeeAgreement	40490	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	700	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	729885	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	410288	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1860507	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	568472	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	133334	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-978052	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-291246	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1201920	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	8970	usd
CY2021Q1	ILAL	Stock Issued During Period Value Commitment Shares Issued StockIssuedDuringPeriodValueCommitmentSharesIssued	130900	usd
CY2021Q1	ILAL	Stock Issued During Period Value Against Accrued Interest Due To Related Party StockIssuedDuringPeriodValueAgainstAccruedInterestDueToRelatedParty	10999	usd
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	45000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	347380	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-990483	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-1664154	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	29521	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	100000	usd
CY2021Q2	ILAL	Stock Issued During Period Value Equity Method Investments StockIssuedDuringPeriodValueEquityMethodInvestments	2580000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000	usd
CY2021Q2	ILAL	Stock Issued During Period Value Pursuant To Consulting Agreements StockIssuedDuringPeriodValuePursuantToConsultingAgreements	259108	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1307078	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1974830	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	641723	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1739750	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	78485	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-642057	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1802901	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4331281	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3607370	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1281976	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2001021	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1310497	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10876	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	39708	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35311	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-231845	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39212	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	291374	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	284616	usd
	ILAL	Excess Fair Value Of Derivative ExcessFairValueOfDerivative	356785	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	219069	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25199	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-45557	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-157212	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-235002	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	287596	usd
	ILAL	Increase Decrease In Accounts Payable And Accrued Liabilities One IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesOne	411305	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	8379	usd
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	5919	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	340882	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	37000	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	500	usd
	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	137980	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-506041	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-703349	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	100000	usd
	ILAL	Cash Payment To Collaborative Agreement CashPaymentToCollaborativeAgreement	100000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	444535	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	241259	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-444535	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-441259	usd
	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash	1804750	usd
	ILAL	Common Stock Issued From Options Exercise CommonStockIssuedFromOptionsExercise	1300	usd
	ILAL	Common Stock Warrants And Plots Promised For Cash Net CommonStockWarrantsAndPlotsPromisedForCashNet	100000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	262596	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	510661	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	89474	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	982086	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	663250	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	288874	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	677347	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	763812	usd
	ILAL	Cash Proceeds From Refinancing Net CashProceedsFromRefinancingNet	368736	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	989827	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1833425	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39251	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	688817	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56590	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13171	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	95841	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	701988	usd
	us-gaap	Interest Paid Net InterestPaidNet	115084	usd
	us-gaap	Interest Paid Net InterestPaidNet	127174	usd
	ILAL	Dividend On Series B DividendOnSeriesB	45000	usd
	ILAL	Dividend On Series B DividendOnSeriesB	45000	usd
	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	102200	usd
	ILAL	Debt Discount From Bifurcated Derivative DebtDiscountFromBifurcatedDerivative	140750	usd
	ILAL	Common Stock Issued For Finders Fee Agreement CommonStockIssuedForFindersFeeAgreement	40490	usd
	ILAL	Debt Discount Created From Warrants Embedded In Financing DebtDiscountCreatedFromWarrantsEmbeddedInFinancing	159664	usd
	ILAL	Corporate Expenses Paid By Related Party Note CorporateExpensesPaidByRelatedPartyNote	49145	usd
	ILAL	Shares Issued With Debt Modification SharesIssuedWithDebtModification	8970	usd
	ILAL	Cancellation Of Previously Issued Common Stock CancellationOfPreviouslyIssuedCommonStock	315288	usd
	ILAL	Interest On Notes Paid By Related Party InterestOnNotesPaidByRelatedParty	17734	usd
	ILAL	Construction In Progress Paid By Related Party ConstructionInProgressPaidByRelatedParty	84614	usd
	ILAL	Common Stock Issued As Consideration For Equitymethod Investee CommonStockIssuedAsConsiderationForEquitymethodInvestee	2580000	usd
	ILAL	Commitment Shares Issued With Convertible Note CommitmentSharesIssuedWithConvertibleNote	202275	usd
	ILAL	Commitment Shares Issued With Convertible Note CommitmentSharesIssuedWithConvertibleNote	130900	usd
	ILAL	Corporate Expenses Paid Through Related Party Note CorporateExpensesPaidThroughRelatedPartyNote	25462	usd
	ILAL	Common Stock Issued In Settlement Of Related Party Accrued Interest On Note CommonStockIssuedInSettlementOfRelatedPartyAccruedInterestOnNote	10999	usd
CY2022Q3	ILAL	Working Capital WorkingCapital	5700000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4300000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19000000.0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-506000	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	90500	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	48600	usd
	ILAL	Aggregate Interest Amount AggregateInterestAmount	125100	usd
	ILAL	Expenses Paid By Related Party ExpensesPaidByRelatedParty	35700	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zWlrLr8zjQFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_ze4tEK9Utzb9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful life of buildings.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowances.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived asset for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	3867500	shares
CY2022Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	278466	usd
CY2022Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	278466	usd
CY2022Q3	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	15000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	45000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3180000	shares
CY2021Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.69
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P5Y29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	687500	shares
	us-gaap	Advertising Expense AdvertisingExpense	903283	usd
	us-gaap	Advertising Expense AdvertisingExpense	1276200	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7717500	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6230000	shares
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.80
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted	P4Y5M26D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3867500	shares
CY2022Q3	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.71
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z3bWR8v1TxFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zajcZa2Ec9jg">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through September 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zKvxJvqaX0mg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zHEutay5pwXe">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to prior year’s data to confirm to the current year’s presentation. Such reclassifications had no impact on the Company’s financial condition, operating results, cash flows or stockholders’ deficit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2019Q1	us-gaap	Business Combination Contingent Consideration Asset BusinessCombinationContingentConsiderationAsset	1122050	usd
	us-gaap	Interest Expense Other InterestExpenseOther	45000	usd
CY2021Q3	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	99000	usd
CY2021Q3	ILAL	Construction Contract For Consideration Funded ConstructionContractForConsiderationFunded	20000	usd
	ILAL	Customer Funded Additional Amount CustomerFundedAdditionalAmount	24000	usd
	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	44000	usd
	ILAL	Payable Consideration Percentage PayableConsiderationPercentage	0.44	pure
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	171291	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132254	usd
CY2022Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	876847	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	915884	usd
	us-gaap	Depreciation Depreciation	39708	usd
CY2021	us-gaap	Depreciation Depreciation	35311	usd
	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	1600000	usd
CY2022Q3	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	282570	usd
CY2022Q3	ILAL	Notes Payable Gross NotesPayableGross	2573872	usd
CY2021Q4	ILAL	Notes Payable Gross NotesPayableGross	1889762	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	364974	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	51462	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	2208898	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	1838300	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2208898	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	102762	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1735538	usd
	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding	P4Y4M9D
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1298880	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	834984	usd
	ILAL	Repayment Of Promissory From Related Parties RepaymentOfPromissoryFromRelatedParties	46765	usd
	ILAL	Commitment To Purchase Of Land CommitmentToPurchaseOfLand	The land project consisting of 20 acres to be acquired from Baja Residents Club (a Company controlled by our CEO Roberto Valdes) and developed into Valle Divino resort in Ensenada, Baja California, the acquisition of title to the land for this project is subject to approval from the Mexican government in Baja, California
CY2022Q3	us-gaap	Area Of Land AreaOfLand	20
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36471365	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36471365	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31849327	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31849327	shares
	ILAL	Stock Issued During Period Shares Existing Finders Fee StockIssuedDuringPeriodSharesExistingFindersFee	88988	shares
	ILAL	Stock Issued During Period Values Existing Finders Fee StockIssuedDuringPeriodValuesExistingFindersFee	40490	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	65000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000	shares
CY2021Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3000000	shares
CY2022Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3850000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P4Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1300000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.001
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P5Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1300000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.001
	ILAL	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1	P5Y
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3850000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.41
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M21D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3850000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	716000	usd

Files In Submission

Name	View Source	Status
ilal-20220930_cal.xml	Edgar Link	unprocessable
0001493152-22-033071-index-headers.html	Edgar Link	pending
0001493152-22-033071-index.html	Edgar Link	pending
0001493152-22-033071.txt	Edgar Link	pending
0001493152-22-033071-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ilal-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
ilal-20220930_lab.xml	Edgar Link	unprocessable
ilal-20220930_pre.xml	Edgar Link	unprocessable
ilal-20220930_def.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2022 Q4 Form 10-Q Financial Statement

#000149315222033071 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2022 Q4 Form 10-Q Financial Statement

#000149315222033071 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal